(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202406 | 202306 | % Var | 202406 | 202306 | % Var | 202403 | 202303 | % Var | |
| Sales | 45010.50 | 39219.00 | 14.77 | 45010.50 | 39219.00 | 14.77 | 165743.40 | 143453.40 | 15.54 |
| Other Income | 2135.20 | 1579.80 | 35.16 | 2135.20 | 1579.80 | 35.16 | 10706.60 | 4567.90 | 134.39 |
| PBIDT | 15733.80 | 12341.90 | 27.48 | 15733.80 | 12341.90 | 27.48 | 55548.10 | 38096.80 | 45.81 |
| Interest | 50.70 | 3.10 | 1535.48 | 50.70 | 3.10 | 1535.48 | 202.50 | 222.70 | -9.07 |
| PBDT | 15683.10 | 12338.80 | 27.10 | 15683.10 | 12338.80 | 27.10 | 55345.60 | 36015.10 | 53.67 |
| Depreciation | 1378.60 | 1359.50 | 1.40 | 1378.60 | 1359.50 | 1.40 | 5875.90 | 5959.10 | -1.40 |
| PBT | 14304.50 | 10979.30 | 30.29 | 14304.50 | 10979.30 | 30.29 | 49469.70 | 30056.00 | 64.59 |
| TAX | 3745.10 | 2990.50 | 25.23 | 3745.10 | 2990.50 | 25.23 | 12327.80 | 8615.40 | 43.09 |
| Deferred Tax | 165.90 | -89.50 | -285.36 | 165.90 | -89.50 | -285.36 | 60.90 | -400.90 | -115.19 |
| PAT | 10559.40 | 7988.80 | 32.18 | 10559.40 | 7988.80 | 32.18 | 37141.90 | 21440.60 | 73.23 |
| Equity | 1615.00 | 1614.50 | 0.03 | 1615.00 | 1614.50 | 0.03 | 1614.70 | 1614.30 | 0.02 |
| PBIDTM(%) | 34.96 | 31.47 | 11.08 | 34.96 | 31.47 | 11.08 | 33.51 | 26.56 | 26.20 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: